A multicenter, prospective, controlled, randomized (moderate hypothermia 33°C≤ T°C ≤34°C) during 24 hours ± 1h versus normothermia (37°C ± 0.3 °C), comparative open trial will be conducted on two parallel groups of patients with cardiogenic shock treated with VA-ECMO.